Acute adrenal insufficiency in a patient with panhypopituitarism after vaccination against COVID-19 (BNT162b2 Pfizer-BioNTech)
Endocrinol Diabetes Nutr (Engl Ed)
.
2022 Nov;69(9):762-763.
doi: 10.1016/j.endien.2021.11.035.
Epub 2022 Nov 14.
Authors
Javier González López
1
,
Dianis Escorcio Faria
2
,
María Riestra Fernández
3
Affiliations
1
Medicina de Familia y Comunitaria, Hospital Universitario de Cabueñes, Gijón, Spain. Electronic address:
[email protected]
.
2
Servicio de Hematología, Hospital Universitario de Cabueñes, Gijón, Spain.
3
Servicio de Endocrinología, Hospital Universitario de Cabueñes, Gijón, Spain.
PMID:
36428206
PMCID:
PMC9659551
DOI:
10.1016/j.endien.2021.11.035
No abstract available
Publication types
Case Reports
MeSH terms
Acute Disease
Adrenal Insufficiency* / chemically induced
BNT162 Vaccine
COVID-19* / prevention & control
Humans
Hypopituitarism
Vaccination
Substances
BNT162 Vaccine
Supplementary concepts
Combined Pituitary Hormone Deficiency